Valerie Start
Director/Board Member bei ERASCA, INC.
Vermögen: 45 320 $ am 31.03.2024
Profil
Valerie Denise Harding Start is currently an Independent Director at Erasca, Inc., a Member & Partner at Smallify LLC, and the Principal of Start Pharma Consulting LLC.
Previously, she worked as the Vice President-Product Differentiation at Pfizer Inc. from 2009 to 2012 and as the Senior VP-Chemistry, Manufacturing & Controls at Ignyta, Inc. from 2015 to 2019.
Dr. Start holds an undergraduate degree from the University of London and a doctorate degree from The University of Nottingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ERASCA, INC.
0,01% | 01.01.2024 | 22 000 ( 0,01% ) | 45 320 $ | 31.03.2024 |
Aktive Positionen von Valerie Start
| Unternehmen | Position | Beginn |
|---|---|---|
| ERASCA, INC. | Director/Board Member | 01.06.2019 |
| Start Pharma Consulting LLC | Corporate Officer/Principal | 01.02.2019 |
Smallify LLC
 Smallify LLC Miscellaneous Commercial ServicesCommercial Services Smallify LLC provides consulting, training, certification, and tools to help organizations implement rapid innovation practices. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Valerie Start
| Unternehmen | Position | Ende |
|---|---|---|
| IGNYTA INC | Corporate Officer/Principal | 01.01.2019 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Valerie Start
| University of London | Undergraduate Degree |
| The University of Nottingham | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Smallify LLC
Smallify LLC Miscellaneous Commercial ServicesCommercial Services Smallify LLC provides consulting, training, certification, and tools to help organizations implement rapid innovation practices. | Commercial Services |
| Start Pharma Consulting LLC |
